Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc. > New Press Release - Theralase(R) Announces Brokered LIFE Financing
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(340)
•••
Comment by BudFoxx2020on Oct 24, 2023 5:58pm
187 Views
Post# 35699128

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:New Press Release - Theralase(R) Announces Brokered LIFE Financing

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:New Press Release - Theralase(R) Announces Brokered LIFE FinancingLol here is the second biggest promoter beside SF.  His M.O. attack any poster.  Spin, spin, spin gerbel.  This promoter was here in 2015 when share price was over 0.50 cents.  He promised billions and $100 share price.  Today it sits at 0.20 cents almost 9 years later.  Yep I am embarassing myself.  Have some dignity.  You are a failure in life, get a better job.  Stop promoting and hustling old mom and pops, I know there are a lot of senior investors in TLT.  Even management don't go out of their way to make these ridiculous claims like Gerbil does over the years.  I hope he is held responsible along with ScienceFirst.  What a clown.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities